11/04/2024

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

11/04/2024

Apr 11, 2024, 12:21 | Blog
Paolo Tarantino: Easier to get a ticket for a Taylor Swift concert than to find a seat at the AACR24 Next Generation ADC session!
Paolo Tarantino, Advanced Research Fellow in the Breast Oncology Program at Dana-Farber Cancer Institute, shared…
Apr 11, 2024, 12:10 | Blog
CD70-Targeted Allogeneic CAR T-Cell Therapy for Advanced Clear Cell Renal Cell Carcinoma, by Sumanta K. Pal et al - Cancer Discovery
Cancer Discovery shared on X/Twitter: "Just published with the AACR24 Clinical Plenary presentation: CD70-Targeted Allogeneic CAR…
Apr 11, 2024, 11:56 | Blog
Guru P. Sonpavde: AACR⁩ - Many promising options for Phase I clinical trials
Guru P. Sonpavde, GU Oncology Director at Advent Health Cancer Institute, shared on X/Twitter: "AACR24 ⁦AACR⁩…
Apr 11, 2024, 11:47 | Career
Congratulations to Mariana Xavier Byndloss on receiving the Excellence in Science Early Career Investigator Award - HHMI NEWS
HHMI NEWS shared on X: “Congratulations to Mariana Xavier Byndloss, Freeman Hrabowski Scholar and Vanderbilt…
Apr 11, 2024, 11:40 | Societies
Congrats to the 2024 Excellence in Science Awards recipients - The Federation of American Societies for Experimental Biology (FASEB)
The Federation of American Societies for Experimental Biology (FASEB) shared a post on X: “Congrats…
Apr 11, 2024, 08:24 | Career
Mariana Byndloss: What an honour to receive the 2024 Excellence in Science Award from FASEB!
Mariana Byndloss, Assistant Professor at Vanderbilt University Medical Center, shared a post by Federation of…
Apr 11, 2024, 08:18 | Blog
Mariam Jamal-Hanjani’s talk highlights need for biomarkers to identify patients at risk of developing cachexia - LUNGevity Foundation
LUNGevity Foundation shared a post on X: “Mariam Jamal-Hanjani’s talk highlights need for biomarkers to…
Apr 11, 2024, 08:13 | Drugs
Tom Powles: Disitimab, Vedotin and Pembrolizumab vs chemotherapy with or without Avelumab in advanced Urothelial Carcinoma
Tom Powles, Director of Barts Cancer Center, recently shared on X: “Trial in progress: The…
Apr 11, 2024, 08:07 | Positive
Francesco Caiazza: When I walked into an AMC event in 2016 at my first ever AACR annual meeting, I didn’t know that I was going to find a family
Francesco Caiazza, Senior Scientist in Translational Medicine at CytomX Therapeutics, shared on X:  “When I…
Apr 11, 2024, 07:39 | Blog
Elie G. Dib: In our recent article we assigned genomic alterations to each hallmark and uncovered some intriguing patterns
Quoting Elie G. Dib, Associate Director of the Haematology-Oncology Training Program at Saint Joseph Mercy…
All: 75 Posts: 61 - 70
Special Coverage